The clinicopathologic significance of FOXC1 in BRCA-mutant breast cancer.

被引:0
|
作者
Choi, Michael Phillip
Cui, Xiaojiang
Dadmanesh, Farnaz
Liles, Georgia
Zhang, Xiao
Karlan, Beth
Glullano, Armando E.
Amersi, Farin F.
机构
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Santa Monica, CA USA
关键词
D O I
10.1200/jco.2014.32.15_suppl.1556
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1556
引用
收藏
页数:1
相关论文
共 50 条
  • [41] FOXC1 plays a crucial role in the growth of pancreatic cancer
    Ramadevi Subramani
    Fernando A. Camacho
    Carly Ivy Levin
    Kristina Flores
    Alexa Clift
    Adriana Galvez
    Mauricio Terres
    Servando Rivera
    Sai Navana Kolli
    Joshua Dodderer
    Megan Miranda
    Alejandro Rodriguez
    Diego A. Pedroza
    Animesh Chatterjee
    Rajkumar Lakshmanaswamy
    Oncogenesis, 7
  • [42] FOXC1 restrains NF-κB-mediated interleukin-1β transcription in breast cancer
    Liu, Yan
    Chen, Shuang
    Tian, Mao
    Giuliano, Armando
    Cui, Xiaojiang
    MEDCOMM, 2023, 4 (06):
  • [43] FOXC1 plays a crucial role in the growth of pancreatic cancer
    Subramani, Ramadevi
    Camacho, Fernando A.
    Levin, Carly Ivy
    Flores, Kristina
    Clift, Alexa
    Galvez, Adriana
    Terres, Mauricio
    Rivera, Servando
    Kolli, Sai Navana
    Dodderer, Joshua
    Miranda, Megan
    Rodriguez, Alejandro
    Pedroza, Diego A.
    Chatterjee, Animesh
    Lakshmanaswamy, Rajkumar
    ONCOGENESIS, 2018, 7
  • [44] Intracranial evaluation of the in vivo pharmacokinetics, brain distribution, and efficacy of rucaparib in BRCA-mutant, triple-negative breast cancer
    Minh Nguyen
    Robillard, Liliane
    Harding, Thomas C.
    Xiao, Jim J.
    Simmons, Andrew D.
    Kristeleit, Hartmut
    Liao, Michelle
    CANCER RESEARCH, 2019, 79 (13)
  • [45] FOXC1 expression is associated with a triple-negative basal-like phenotype in breast cancer
    Cho, William C.
    Ma, Victor W.
    Cheuk, Wah
    So, Grace Y.
    Chin, Rebecca Y.
    CANCER RESEARCH, 2020, 80 (16)
  • [46] Clinicopathologic features of bilateral breast cancer.
    Sahin, A
    Cunningham, J
    Bondy, M
    Aldaz, C
    MODERN PATHOLOGY, 1998, 11 (01) : 26A - 26A
  • [47] Clinicopathologic features of bilateral breast cancer.
    Sahin, A
    Cunningham, J
    Bondy, M
    Aldaz, C
    LABORATORY INVESTIGATION, 1998, 78 (01) : 26A - 26A
  • [48] Efficacy and pharmacokinetics of niraparib in BRCA-mutant and wild-type intracranial triple negative breast cancer murine models
    Sambade, Maria
    Van Swearingen, Amanda
    Sun, Kaiming
    Wang, Jing
    Mikule, Kevin
    Anders, Carey K.
    CANCER RESEARCH, 2018, 78 (13)
  • [49] The role of FOXC1/FOXCUT/DANCR axis in triple negative breast cancer: a bioinformatics and experimental approach
    Kamaliyan, Zeeba
    Mirfakhraie, Reza
    Azizi-Tabesh, Ghasem
    Darbeheshti, Farzaneh
    Omranipour, Ramesh
    Ahmadinejad, Nasrin
    Zokaei, Elham
    Yassaee, Vahid-Reza
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (04) : 2821 - 2829
  • [50] The role of FOXC1/FOXCUT/DANCR axis in triple negative breast cancer: a bioinformatics and experimental approach
    Zeeba Kamaliyan
    Reza Mirfakhraie
    Ghasem Azizi-Tabesh
    Farzaneh Darbeheshti
    Ramesh Omranipour
    Nasrin Ahmadinejad
    Elham Zokaei
    Vahid-Reza Yassaee
    Molecular Biology Reports, 2022, 49 : 2821 - 2829